380 related articles for article (PubMed ID: 29323026)
1. The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies.
Dulamea AO
Neural Regen Res; 2017 Dec; 12(12):1939-1944. PubMed ID: 29323026
[TBL] [Abstract][Full Text] [Related]
2. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
Skaper SD
Prog Brain Res; 2019; 245():119-144. PubMed ID: 30961866
[TBL] [Abstract][Full Text] [Related]
3. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
4. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
5. Engineering biomaterial microenvironments to promote myelination in the central nervous system.
Unal DB; Caliari SR; Lampe KJ
Brain Res Bull; 2019 Oct; 152():159-174. PubMed ID: 31306690
[TBL] [Abstract][Full Text] [Related]
6. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
Dulamea AO
Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
[TBL] [Abstract][Full Text] [Related]
7. Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis.
Gacem N; Nait-Oumesmar B
Life (Basel); 2021 Apr; 11(4):. PubMed ID: 33918664
[TBL] [Abstract][Full Text] [Related]
8. MiR-146a promotes oligodendrocyte progenitor cell differentiation and enhances remyelination in a model of experimental autoimmune encephalomyelitis.
Zhang J; Zhang ZG; Lu M; Zhang Y; Shang X; Chopp M
Neurobiol Dis; 2019 May; 125():154-162. PubMed ID: 30707940
[TBL] [Abstract][Full Text] [Related]
9. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
10. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Wegener A; Deboux C; Bachelin C; Frah M; Kerninon C; Seilhean D; Weider M; Wegner M; Nait-Oumesmar B
Brain; 2015 Jan; 138(Pt 1):120-35. PubMed ID: 25564492
[TBL] [Abstract][Full Text] [Related]
11. Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
Cui QL; Kuhlmann T; Miron VE; Leong SY; Fang J; Gris P; Kennedy TE; Almazan G; Antel J
Am J Pathol; 2013 Aug; 183(2):516-25. PubMed ID: 23746653
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.
Yin W; Hu B
Exp Neurol; 2014 Jan; 251():72-83. PubMed ID: 24262204
[TBL] [Abstract][Full Text] [Related]
13. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
Moll NM; Hong E; Fauveau M; Naruse M; Kerninon C; Tepavcevic V; Klopstein A; Seilhean D; Chew LJ; Gallo V; Nait Oumesmar B
Glia; 2013 Oct; 61(10):1659-72. PubMed ID: 23918253
[TBL] [Abstract][Full Text] [Related]
14. Oligodendrocyte Intrinsic miR-27a Controls Myelination and Remyelination.
Tripathi A; Volsko C; Garcia JP; Agirre E; Allan KC; Tesar PJ; Trapp BD; Castelo-Branco G; Sim FJ; Dutta R
Cell Rep; 2019 Oct; 29(4):904-919.e9. PubMed ID: 31644912
[TBL] [Abstract][Full Text] [Related]
15. Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Zhang J; Zhang ZG; Li Y; Lu M; Zhang Y; Elias SB; Chopp M
Neurobiol Dis; 2016 Apr; 88():85-95. PubMed ID: 26805386
[TBL] [Abstract][Full Text] [Related]
16. LINGO-1 Regulates Oligodendrocyte Differentiation through the Cytoplasmic Gelsolin Signaling Pathway.
Shao Z; Lee X; Huang G; Sheng G; Henderson CE; Louvard D; Sohn J; Pepinsky B; Mi S
J Neurosci; 2017 Mar; 37(12):3127-3137. PubMed ID: 28193690
[TBL] [Abstract][Full Text] [Related]
17. miRNAs As Emerging Regulators of Oligodendrocyte Development and Differentiation.
Galloway DA; Moore CS
Front Cell Dev Biol; 2016; 4():59. PubMed ID: 27379236
[TBL] [Abstract][Full Text] [Related]
18. GD1a Overcomes Inhibition of Myelination by Fibronectin via Activation of Protein Kinase A: Implications for Multiple Sclerosis.
Qin J; Sikkema AH; van der Bij K; de Jonge JC; Klappe K; Nies V; Jonker JW; Kok JW; Hoekstra D; Baron W
J Neurosci; 2017 Oct; 37(41):9925-9938. PubMed ID: 28899916
[TBL] [Abstract][Full Text] [Related]
19. Thyroid Hormone Potentially Benefits Multiple Sclerosis via Facilitating Remyelination.
Zhang M; Ma Z; Qin H; Yao Z
Mol Neurobiol; 2016 Sep; 53(7):4406-16. PubMed ID: 26243185
[TBL] [Abstract][Full Text] [Related]
20. Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.
Talbott JF; Loy DN; Liu Y; Qiu MS; Bunge MB; Rao MS; Whittemore SR
Exp Neurol; 2005 Mar; 192(1):11-24. PubMed ID: 15698615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]